Striatal Neurons In Tardive Dyskinesia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Striatal neurons in tardive dyskinesia refer to the medium spiny neurons (MSNs) of the striatum that are affected by long-term antipsychotic drug exposure. Tardive dyskinesia (TD) is a movement disorder characterized by involuntary, repetitive movements. The striatum, particularly the indirect pathway MSNs, is highly vulnerable to dopamine D2 receptor blockade and subsequent neuroplastic changes.
Tardive dyskinesia (TD) is a serious movement disorder caused by prolonged antipsychotic drug exposure. It involves dysfunction of striatal GABAergic neurons and their modulatory systems.
The study of Striatal Neurons In Tardive Dyskinesia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Cornett EM, et al. Tardive dyskinesia: a review. Innov Clin Neurosci. 2017.
[2] Waln O, Jankovic J. Tardive dyskinesia. Neurol Clin. 2015.
[3] Cloud LJ, et al. Treatment of tardive dyskinesia. Curr Treat Options Neurol. 2014.